XDx links with LabCorp in lupus licensing deal

XDx Inc will work with Laboratory Corporation of America Holdings to develop a test used on lupus patients.

The test will attempt to predict when the active phase of the autoimmune disease is likely to "flare up," thus making treatment more precise and less harmful to patients.